KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.253
-0.025 (-9.06%)
Mar 9, 2026, 3:23 PM EDT - Market open
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $7.14 million as of March 9, 2026. Its market cap has decreased by -77.32% in one year.
Market Cap
7.14M
Enterprise Value
16.05M
1-Year Change
-77.32%
Ranking
Category
Stock Price
$0.25
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $7.14M, a decrease of -98.34%. That is a compound annual growth rate of -37.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.30M | -50.00% |
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iterum Therapeutics | 8.74M |
| CollPlant Biotechnologies | 8.73M |
| Bolt Biotherapeutics | 8.25M |
| PharmaCyte Biotech | 8.08M |
| Alaunos Therapeutics | 8.06M |
| Ernexa Therapeutics | 7.72M |
| Alzamend Neuro | 7.53M |
| Addex Therapeutics | 7.49M |